Amarin Corp Plc (AMRN)

[Jasbg]

I guess we all have to admit to ourselves 'Again' that this 'in the market' has until now been a very disappointing day.
----------------------------------

First - I'm not gonna blame Amarin this time. Truly feel they did everything possible to 'sell the fabulous information' on the early Covid trials. Even making a very fine webcast - with 3 of the most brilliant minds on the planet on EPA and Vascepa knowledge.
----------------------------------

The hard facts right now is 'that A Cure on Cancer (which Vascepa in fact has possible potential of being to at least some forms) would/will not move the SP for real.

The forces that Leland Gershell - and Adam Feuerstein - was talking about right after CDV approval december 2019 (when SP was $24- 26) - we have to realize - HAVE WON - until now. This stock is simply 'not aloud to go anywhere'.
---------------------------------

Right now You Wonder if even 'getting patents restored' - would bring back the SP in the twenties. Everytime (and I mean EVERYTIME) the SP starts moving - Soon there is a number of Red Bares - bringing it down again. That's reality right now - like it or not.

For Amarin - company are 'also locked to a big extend' - with being so undervalued (SP locked around $5) it's hard to negotiate a reasonable BO deal - which is probably 'part of' WHY this stock is being ever held down/locked.

What Covid Crisis has shown us repeatetly, is' - that Big Pharma/Bio Business - Is Also' a very' very' cynical game on billions and billions of dollars. And learning/realizing the potential of Vascepa - Amarin has been/is drawn into 'this game'.
---------------------------------

How to 'break free' - of Options - Shorters 'and the controlling BP forces' - That's the big Question. What we have learned is' that 'Good news (after gate opened for generics to enter) does not really move the markets.

And it is a bad circle here for Amarin - at this SP value - company miss the power also to use the money needed for marketing hard enough - to start making the money that would make SP rise.

What to do about it ? Not that easy. Timing is everything 'it is often said' - and this also goes for Vascepa. Time is not on our side - as the number of Covid trials is still months away - EU GIA - is scaring Investors (again takes to long).

Maybe the best hope is Marjac winning Rule 60 Trial in Nevada (if it is actually filed). Something has to happen 'to break the deadlock' - that has been put on Amarin :)

Jasbg